VAZZANA, NATALE
 Distribuzione geografica
Continente #
NA - Nord America 982
EU - Europa 941
AS - Asia 507
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 2.433
Nazione #
US - Stati Uniti d'America 981
CN - Cina 218
FR - Francia 161
UA - Ucraina 152
IE - Irlanda 149
SE - Svezia 134
SG - Singapore 123
TR - Turchia 113
GB - Regno Unito 111
IT - Italia 102
DE - Germania 61
IN - India 45
FI - Finlandia 39
RU - Federazione Russa 20
AT - Austria 4
VN - Vietnam 3
BE - Belgio 2
EU - Europa 2
GR - Grecia 2
CA - Canada 1
CL - Cile 1
IL - Israele 1
JP - Giappone 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MT - Malta 1
NL - Olanda 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.433
Città #
Jacksonville 188
Chandler 187
Dublin 148
Singapore 110
Southend 102
Dearborn 70
Princeton 63
Izmir 59
Nanjing 52
Ashburn 47
Beijing 46
Santa Clara 35
Wilmington 34
Cambridge 32
Altamura 29
Nanchang 27
Ann Arbor 19
Chieti 19
Kunming 12
Hebei 10
Jiaxing 10
Munich 10
Boardman 9
Helsinki 8
Los Angeles 8
Pescara 7
Washington 7
Changsha 6
Hangzhou 6
Shenyang 6
Woodbridge 6
Tianjin 5
Grevenbroich 4
Jinan 4
New York 4
Norwalk 4
Anzola Dell'emilia 3
Dong Ket 3
Guangzhou 3
Rome 3
Seattle 3
Shanghai 3
Boscotrecase 2
Brussels 2
Changchun 2
Falls Church 2
Hefei 2
Lanzhou 2
Misterbianco 2
Monmouth Junction 2
Moscow 2
Paris 2
Roseto degli Abruzzi 2
San Francisco 2
San Mateo 2
Tappahannock 2
West Covina 2
Albano Laziale 1
Athens 1
Augusta 1
Bellante 1
Bergamo 1
Bratislava 1
Brentonico 1
Catania 1
Chengdu 1
Chongqing 1
Colombo 1
Dallas 1
Düsseldorf 1
Fuzhou 1
Greifswald 1
Jinhua 1
Leipzig 1
London 1
Melita 1
Mountain View 1
Nanping 1
Newcastle Upon Tyne 1
Newcastle upon Tyne 1
Ningbo 1
Novokuznetsk 1
Orange 1
Phnom Penh 1
Phoenix 1
Romola 1
Shenzhen 1
Tokyo 1
Torino 1
Toronto 1
Vientiane 1
West Chester 1
Xian 1
Zgierz 1
Zhengzhou 1
Ürümqi 1
Totale 1.480
Nome #
Pentraxin 3 and platelet activation in obese patients after gastric banding 121
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 115
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 115
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 113
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 100
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 92
Platelet activation in obesity and metabolic syndrome. 89
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 89
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 85
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 84
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 84
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 84
Soluble forms of RAGE in internal medicine. 83
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 82
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 82
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 81
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 80
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 79
Thromboxane-Dependent Platelet Activation After Gastric Banding for Obesity. 77
Diabetes mellitus and thrombosis 75
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 75
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 70
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation. 68
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 67
Obesity-driven inflammation and colorectal cancer 67
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients 66
Variability in the response to antiplatelet treatment in diabetes mellitus. 65
Diabetes mellitus 64
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low-HDL Phenotype 62
Plasma Levels Of Soluble CD36 In Type 2 Diabetes - A Link Between Platelet Activation, Inflammation And Oxidative Stress. 61
Platelet Function in Health and Disease: from Molecular Mechanisms, Redox Considerations to Novel Therapeutic Opportunities. 55
Biomarkers of platelet activation in acute coronary syndromes 55
Totale 2.585
Categoria #
all - tutte 9.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020304 0 0 0 0 0 52 62 54 12 70 49 5
2020/2021184 33 2 36 0 4 43 11 6 11 28 4 6
2021/2022177 1 7 2 57 8 4 3 13 13 12 15 42
2022/2023513 38 83 31 46 50 106 26 32 75 9 6 11
2023/2024232 15 14 12 6 17 58 59 9 14 9 1 18
2024/2025271 25 110 100 13 14 9 0 0 0 0 0 0
Totale 2.585